Liang Shan

Dr. Liang Shan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LSLiang Shan
Liang Shan
FWFengling Wang
Fengling Wang
DZDandan Zhai
Dandan Zhai
XMXiangyun Meng
Xiangyun Meng
JLJianjun Liu
Jianjun Liu
XLxiongwen lv
xiongwen lv
Liver fibrosis is the common consequence of various chronic liver injuries and is mainly characterized by the imbalance between the production and degradation of extracellular matrix, which leads to the accumulation of interstitial collagen and other matrix components. Matrix metalloproteinases (MMPs) and their specific inhibitors, that is, tissue inhibitors of metalloproteinases (TIMPs), play a crucial role in collagen synthesis and lysis. Previous in vivo and in vitro studies of our laboratory found repressing extracellular matrix (ECM) accumulation by restoring the balance between MMPs and TIMPs can alleviate liver fibrosis. We conducted a review of articles published in PubMed and Science Direct in the last decade until February 1, 2023, which were searched for using these words "MMPs/TIMPs" and "Hepatic Fibrosis." Through a literature review, this article reviews the experimental studies of liver fibrosis based on MMPs/TIMPs, summarizes the components that may exert an anti-liver fibrosis effect by affecting the expression or activity of MMPs/TIMPs, and attempts to clarify the mechanism of MMPs/TIMPs in regulating collagen homeostasis, so as to provide support for the development of anti-liver fibrosis drugs. We found the MMP-TIMP-ECM interaction can result in better understanding of the pathogenesis and progression of hepatic fibrosis from a different angle, and targeting this interaction may be a promising therapeutic strategy for hepatic fibrosis. Additionally, we summarized and analyzed the drugs that have been found to reduce liver fibrosis by changing the ratio of MMPs/TIMPs, including medicine natural products.

9 October 2025 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
LSLiang Shan
Liang Shan
CWChuanying Wang
Chuanying Wang
XFXing Fang
Xing Fang
ZZZhengsheng Zhang
Zhengsheng Zhang
SDShujuan Dai
Shujuan Dai
JLJianjun Liu
Jianjun Liu
Studies have shown that long-term coffee consumption is significantly inversely associated with the risk of hepatocellular carcinoma (HCC). It has been shown that caffeine (a naturally occurring compound) can inhibit HCC in animal models. However, the mechanism of caffeine on the prevention and treatment of HCC has not been fully clarified. Diethylnitrosamine (DEN) is considered a potent carcinogen. Based on literature in China and overseas, we adopted a DEN-induced HCC model in rats to observe the preventive and therapeutic effects of caffeine on HCC induced by DEN in rats and elucidate the mechanisms. We found that caffeine had protective effects on HCC induced by DEN in rats through inhibition of ‌cyclic adenosine monophosphate-protein kinase A-cAMP-response element binding protein‌ (cAMP-PKA-CREB) signaling. This study provides: (i) an in vivo and in vitro experimental basis for the application of caffeine in the clinical prevention and treatment of HCC; (ii) new perspectives for the evaluation and screening of efficacious drugs for the prevention and treatment of HCC.

1 January 2018 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
LSLiang Shan
Liang Shan
BWBaoming Wu
Baoming Wu
LZLing Zhang
Ling Zhang
BSBiao Song
Biao Song
Background: Ginsenoside Rg1, the active ingredient of natural plants, has been proved to have anti-liver fibrosis activity. However, the specific mechanism behind these effects has not been determined. This study aims to inverstigate the specific mechanism of the antihepatic fibrosis of ginsenoside Rg1. Methods: The rat model of hepatic fibrosis induced by Concanavalin A (Con A) were established and hepatic stellate cells were isolated. Then hepatic fibrosis and cell damage were evaluated and inverstigated the mechanism. Findings: We found that the anti-hepatic fibrosis effect of ginsenoside Rg1 was related to JAK2/STAT3 signaling pathway and IL-1β, IL-6, IL-10. In addition, the expression of IL-1β, IL-6, IL-10, α-SMA, TGF-β, CollaⅠ and CollaⅡ mRNA in rats treated with different doses of ginsenoside Rg1 for 8 weeks were decreased compared with model group, and mRNA expression of IL-10 was increased, which was associated with drug dosage. Forthermore, the expression of p-JAK2, p-STAT3, Caspase3, α-SMA, TGF-β, CollaⅠ and CollaⅡ protein decreased, and the degree of decrease was correlated with the dosage of administration. Similar results were detected by Immunohistochemistry. The expression of JAK2 and STAT3 protein were not changed significantly. Besides, flow cytometry revealed that ginsenoside Rg1 could promote hepatic stellate cell (HSC) apoptosis. Interpretation: TTaken together, our results indicate that the anti-fibrotic effect of ginsenoside Rg1 is related to JAK2/STAT3 signaling pathway and IL-1β, IL-6, IL-10, and ginsenoside Rg1 is a potential drug against liver fibrosis. Funding Statement: This study was supported by the National Science Foundation of China (grant 81270498) and the National Science Foundation of China (grant 81500473). Declaration of Interests: The authors declare no conflict of interest Ethics Approval Statement: During these studies, all animal procedures were conducted in accordance with the Anhui Medical University Policy on the Care, Welfare and Treatment of Laboratory Animals and were reviewed the Institutional Animal Care and Use Committee either at Anhui Medical University or by the ethical review process at the institution where the work was performed. The experimental protocol for this study was approved by the Anhui Medical University of Animal welfare, Ethics and Strategy and Anhui Province Key Laboratory of Major Autoimmune Diseases, Hefei, China.

14 November 2025 in Pharmacological Research - Natural Products
Verified
Journal Article
Open access
SDShujuan Dai
Shujuan Dai
LSLiang Shan
Liang Shan
CWChuanyin Wang
Chuanyin Wang
XMXiangyun Meng
Xiangyun Meng
JLJianjun Liu
Jianjun Liu
XLxiongwen lv
xiongwen lv